DOW CHEMICAL CO /DE/
SC 13D/A, 1995-02-28
CHEMICALS & ALLIED PRODUCTS
Previous: WEATHERFORD INTERNATIONAL INC, SC 13G, 1995-02-28
Next: DREYFUS FUND INC, NSAR-B, 1995-02-28






		SECURITIES AND EXCHANGE COMMISSION
		     Washington, D. C.  20549


			  SCHEDULE 13D/A
	     Under the Securities Exchange Act of 1934
			 Amendment No. 19


		      MARION MERRELL DOW INC.
			 (Name of Issuer)


	    COMMON STOCK, par value $0.10 per share
		(Title of Class of Securities)

			    569713-10-0
			  (CUSIP Number)


			  John Scriven
		Vice President and General Counsel
		    The Dow Chemical Company
			  2030 Dow Center
		     Midland, Michigan 48674
			 (517) 636-5914                  
	  (Name, Address and Telephone Number of Person
	Authorized to Receive Notices and Communications)


		
			February 28, 1995
     (Date of Event which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule 13G to 
report the acquisition which is the subject of this Schedule 13D, and is 
filing this Schedule because of Rule 13d-1(b)(3) or (4), check the following 
box [   ].


Check the following box if a fee is being paid with this statement [  ].
</page>
<PAGE>

		      CUSIP No. 569713-10-0
												

1)      Name of Reporting Persons and its       RH Acquisition Corp.,      
       	I.R.S. Identification No.               a wholly owned subsidiary of 
						                                          The Dow Chemical Company
							

2)      Check the Appropriate Box if a          (a)     [   ]  
       	Member of a Group                       (b)     [ x ]
							

3)      SEC Use Only
							

4)      Source of Funds                         AF
							

5)      Check Box if Disclosure of Legal
       	Proceedings is Required Pursuant        [   ]
	to Items 2(d) or 2(e)
							

6)      Citizenship or Place of Organization    Delaware
							

Number of       7)    Sole Voting Power         55,934,100(FN1)  20.2%(FN2)
Shares                                                                  
Beneficially    8)    Shared Voting Power       0
Owned by                                                                
Each            9)    Sole Dispositive Power    55,934,100(FN1)  20.2%2(FN2)
Reporting                                                               
Person With     10)   Shared Dispositive Power  0
												

11)     Aggregate Amount Beneficially           55,934,100(FN1)  20.2%(FN2)
	owned by Each Reporting Person
	as of February 28, 1995
							
12)     Check Box if the Aggregate Amount       [    ]
	in Row (11) Excludes Certain Shares
							

13)     Percent of Class Represented by         20.2%(FN2)
	Amount in Row (11) as of                
	February 28, 1995
							

14)     Type of Reporting Person                CO
</page>
<PAGE>
			 CUSIP No. 569713-10-0
												

1)      Name of Reporting Persons and its       Dow Holdings Inc.,              
        I.R.S. Identification No.               a wholly owned subsidiary of 
						                                          The Dow Chemical Company
							

2)      Check the Appropriate Box if a          (a)     [   ]  
       	Member of a Group                       (b)     [ x ]
							

3)      SEC Use Only
							

4)      Source of Funds                         AF
							

5)      Check Box if Disclosure of Legal        [   ]
       	Proceedings is Required Pursuant        
       	to Items 2(d) or 2(e)
							

6)      Citizenship or Place of Organization    Delaware
							

Number of       7)      Sole Voting Power        75,000,000(FN1)  27.1%(FN2)
Shares                                                                  
Beneficially    8)      Shared Voting Power      0
Owned by                                                                
Each            9)      Sole Dispositive Power   75,000,000(FN1)  27.1%(FN2)
Reporting                                                               
Person With     10)     Shared Dispositive Power 0
												

11)     Aggregate Amount Beneficially            75,000,000(FN1)  27.1%(FN2)
       	owned by Each Reporting Person                                    
	       as of February 28, 1995
							
12)     Check Box if the Aggregate Amount        [   ]
       	in Row (11) Excludes Certain Shares
							

13)     Percent of Class Represented by          27.1%(FN2)
       	Amount in Row (11) as of        
       	February 28, 1995
							

14)     Type of Reporting Person                 CO

</page>                          
<PAGE>
			  CUSIP No. 569713-10-0
												

1)      Name of Reporting Persons and its        The Dow Chemical Company
       	I.R.S. Identification No.                I.R.S. Identification 
						  No. 38-1285128
							

2)      Check the Appropriate Box if a           (a)     [   ]  
       	Member of a Group                        (b)     [ x ]
							

3)      SEC Use Only
							

4)      Source of Funds                          WC, BK, 00
							

5)      Check Box if Disclosure of Legal
	Proceedings is Required Pursuant         [   ]
	to Items 2(d) or 2(e)
							

6)      Citizenship or Place of Organization     Delaware
							

Number of       7)      Sole Voting Power        196,865,790(FN1)  71.1%(FN2)
Shares                                                                  
Beneficially    8)      Shared Voting Power      0
Owned by                                                                
Each            9)      Sole Dispositive Power   196,865,790(FN1)  71.1%(FN2)
Reporting                                                               
Person With     10)     Shared Dispositive Power 0
												

11)     Aggregate Amount Beneficially           196,865,790(FN1)  71.1%(FN2)
	owned by Each Reporting Person
	as of February 28, 1995
							
12)     Check Box if the Aggregate Amount       [   ]
	in Row (11) Excludes Certain Shares
							

13)     Percent of Class Represented by         71.1%(FN2)
	Amount in Row (11) as of        
	February 28, 1995
							

14)     Type of Reporting Person                CO
</page>
<PAGE>
(fn>

FOOTNOTES TO PRECEDING COVER PAGES:

1.      The Dow Chemical Company ("Dow"), directly and through its wholly 
	owned subsidiaries RH Acquisition Corp. ("Acquisition") and Dow 
	Holdings Inc. ("Dow Holdings"), holds 196,865,790 shares of the 
	Issuer's common stock, par value $.10 per share.

2.      Dow's, RH Acquisition's and Dow Holdings' combined percentage 
	ownership of the Issuer's common stock is 71.1%, based on the number 
	of shares of the Issuer's common stock outstanding on February 28, 
	1995, as advised by the Issuer.  
</page>
<PAGE>

This Amendment No. 19 amends the Statement of Schedule 13D filed by The Dow 
Chemical Company ("Dow"), RH Acquisition Corp. ("Acquisition") and Dow 
Holdings Inc. ("Dow Holdings") with the Securities and Exchange Commission on 
August 26, 1994, as previously amended (the "Schedule 13D").  This amendment 
is being filed to reflect a press release issued on February 28, 1995 and as 
further discussed in Item 4, below. 

Item 4. Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the 
following: 

Dow issued a press release on February 28, 1995, the text of which is as 
follows:

February 28, 1995

HOECHST, MARION MERRELL DOW AND DOW CHEMICAL MAKE JOINT ANNOUNCEMENT

The Hoechst Group, Marion Merrell Dow and The Dow Chemical Company announced 
today that they are engaged in discussions concerning the possible negotiated 
acquisition of all of the outstanding shares of Marion Merrell Dow by the
Hoechst Group at a price of $25.75 per share in cash.  Dow presently owns 
approximately 197 million shares, or approximately 71 percent, of Marion 
Merrell Dow's outstanding common stock.

Dow and the Hoechst Group are also discussing the possible acquisition of 
Dow's Latin American pharmaceuticals business for approximately $200 million.

The companies stated that while discussions are ongoing, the boards of 
directors and supervisory boards of the respective companies have not yet met 
to consider the possible transactions, no agreements have been reached and 
there can be no assurance that any agreements will be reached or that any 
transactions will be consummated.  

</page>
<PAGE>

				 SIGNATURE


After due inquiry and to the best of my knowledge and belief, I certify that 
the information set forth in this statement is true, complete and correct. 


Dated:  February 28, 1995                  THE DOW CHEMICAL COMPANY


					   By: /s/ Enrique C. Falla                                            
					   Name:   Enrique C. Falla  
					   Title:  Executive Vice President 
						   and Chief Financial Officer 


				  SIGNATURE


After due inquiry and to the best of my knowledge and belief, I certify that 
the information set forth in this statement is true, complete and correct. 


Dated:  February 28, 1995                 RH ACQUISITION CORP.


					                                     By:  /s/ Eric P. Blackhurst          
 				                                     Name:   Eric P. Blackhurst
					                                     Title:  Vice President and Secretary 


                           				SIGNATURE


After due inquiry and to the best of my knowledge and belief, I certify that 
the information set forth in this statement is true, complete and correct. 


Dated:  February 28, 1995                  DOW HOLDINGS INC.


                                   					   By:  /s/ Enrique C. Falla           
                                   					   Name:   Enrique C. Falla
                                   					   Title:  President

</page>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission